New Zealand markets closed

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.2100+0.3200 (+11.07%)
At close: 04:00PM EDT
3.2386 +0.03 (+0.89%)
After hours: 06:09PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.8900
Open2.9300
Bid3.1900 x 200
Ask3.2400 x 300
Day's range2.9300 - 3.3350
52-week range2.6050 - 9.0800
Volume1,997,909
Avg. volume1,458,245
Market cap465.745M
Beta (5Y monthly)1.27
PE ratio (TTM)N/A
EPS (TTM)-1.5600
Earnings date01 May 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.60
  • GlobeNewswire

    Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024

    SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will host a business update conference call and webcast after market close on Tuesday, April 2, 2024 beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investor

  • GlobeNewswire

    Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference

    SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming TD Cowen 44th Annual Healthcare Conference in Boston, MA. Adaptive Biotechnologies’ management is scheduled to present on Monday, March 4th at 11:10 a.m. Pacific Time / 2:10 p.m. Eastern

  • Insider Monkey

    Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript

    Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript February 14, 2024 Adaptive Biotechnologies Corporation beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.32. Adaptive Biotechnologies Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]